Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives
A Banerjee, S Pathak, VD Subramanium… - Drug discovery today, 2017 - Elsevier
Highlights•Review summarizes the current status of colon cancer and its management
strategies.•Features nanoformulated targeted delivery of anticancer drugs for colon cancer …
strategies.•Features nanoformulated targeted delivery of anticancer drugs for colon cancer …
Molecular dynamics: new frontier in personalized medicine
The field of drug discovery has witnessed infinite development over the last decade with the
demand for discovery of novel efficient lead compounds. Although the development of novel …
demand for discovery of novel efficient lead compounds. Although the development of novel …
[HTML][HTML] Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
M Morkel, P Riemer, H Bläker, C Sers - Oncotarget, 2015 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is characterized by recurrent mutations deregulating key cell
signaling cascades and providing the cancer cells with novel functional traits. Among the …
signaling cascades and providing the cancer cells with novel functional traits. Among the …
[HTML][HTML] Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
M Panczyk - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
During the past two decades the first sequencing of the human genome was performed
showing its high degree of inter-individual differentiation, as a result of large international …
showing its high degree of inter-individual differentiation, as a result of large international …
[HTML][HTML] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - Genes & diseases, 2015 - Elsevier
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
Polymeric nanoparticles for colon cancer therapy: overview and perspectives
Polymeric nanoparticles for colon cancer therapy: overview and perspectives - Journal of
Materials Chemistry B (RSC Publishing) DOI:10.1039/C6TB01925K Royal Society of …
Materials Chemistry B (RSC Publishing) DOI:10.1039/C6TB01925K Royal Society of …
TGFα and amphiregulin paracrine network promotes resistance to EGFR blockade in colorectal cancer cells
Purpose: Targeted inhibition of EGFR with the mAbs cetuximab or panitumumab is a
valuable treatment for RAS wild-type colorectal cancers. The efficacy of EGFR blockade is …
valuable treatment for RAS wild-type colorectal cancers. The efficacy of EGFR blockade is …
[HTML][HTML] Perspective: Does personalized medicine hold the future for medicine?
AA Agyeman, R Ofori-Asenso - Journal of Pharmacy and Bioallied …, 2015 - journals.lww.com
W ith the upsurge of personalizing virtually anything such as mugs, stationery, T‑shirts,
phone cases, gift items and most recently the ongoing personalized Coca‑Cola UK summer …
phone cases, gift items and most recently the ongoing personalized Coca‑Cola UK summer …
Personalized transcranial magnetic stimulation in psychiatry
Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation technique that
allows for modulating the activity of local neural populations and related neural networks …
allows for modulating the activity of local neural populations and related neural networks …
Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data
Tumors consist of different genotypically distinct subpopulations—or subclones—of cells.
These subclones can influence neighboring clones in a process called “clonal interaction.” …
These subclones can influence neighboring clones in a process called “clonal interaction.” …